Innoviva Statistics
Total Valuation
Innoviva has a market cap or net worth of $1.19 billion. The enterprise value is $1.45 billion.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Innoviva has 62.60 million shares outstanding. The number of shares has decreased by -23.51% in one year.
Current Share Class | 62.60M |
Shares Outstanding | 62.60M |
Shares Change (YoY) | -23.51% |
Shares Change (QoQ) | +0.68% |
Owned by Insiders (%) | 0.89% |
Owned by Institutions (%) | 98.20% |
Float | 50.42M |
Valuation Ratios
The trailing PE ratio is 19.23 and the forward PE ratio is 11.98.
PE Ratio | 19.23 |
Forward PE | 11.98 |
PS Ratio | 3.40 |
Forward PS | 3.41 |
PB Ratio | 1.78 |
P/TBV Ratio | 2.71 |
P/FCF Ratio | 7.35 |
P/OCF Ratio | 7.33 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 6.57, with an EV/FCF ratio of 8.96.
EV / Earnings | 22.51 |
EV / Sales | 4.12 |
EV / EBITDA | 6.57 |
EV / EBIT | 8.02 |
EV / FCF | 8.96 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.78.
Current Ratio | 1.79 |
Quick Ratio | 1.57 |
Debt / Equity | 0.78 |
Debt / EBITDA | 2.35 |
Debt / FCF | 3.22 |
Interest Coverage | 7.75 |
Financial Efficiency
Return on equity (ROE) is 9.97% and return on invested capital (ROIC) is 9.70%.
Return on Equity (ROE) | 9.97% |
Return on Assets (ROA) | 9.37% |
Return on Capital (ROIC) | 9.70% |
Revenue Per Employee | $3.15M |
Profits Per Employee | $576,705 |
Employee Count | 112 |
Asset Turnover | 0.29 |
Inventory Turnover | 1.49 |
Taxes
In the past 12 months, Innoviva has paid $9.30 million in taxes.
Income Tax | 9.30M |
Effective Tax Rate | 12.59% |
Stock Price Statistics
The stock price has increased by +29.68% in the last 52 weeks. The beta is 0.53, so Innoviva's price volatility has been lower than the market average.
Beta (5Y) | 0.53 |
52-Week Price Change | +29.68% |
50-Day Moving Average | 19.55 |
200-Day Moving Average | 17.36 |
Relative Strength Index (RSI) | 43.73 |
Average Volume (20 Days) | 845,030 |
Short Selling Information
The latest short interest is 11.60 million, so 18.53% of the outstanding shares have been sold short.
Short Interest | 11.60M |
Short Previous Month | 11.77M |
Short % of Shares Out | 18.53% |
Short % of Float | 23.00% |
Short Ratio (days to cover) | 21.91 |
Income Statement
In the last 12 months, Innoviva had revenue of $352.75 million and earned $64.59 million in profits. Earnings per share was $0.99.
Revenue | 352.75M |
Gross Profit | 297.14M |
Operating Income | 181.34M |
Pretax Income | 153.00M |
Net Income | 64.59M |
EBITDA | 221.19M |
EBIT | 181.34M |
Earnings Per Share (EPS) | $0.99 |
Full Income Statement Balance Sheet
The company has $260.63 million in cash and $521.96 million in debt, giving a net cash position of -$261.33 million or -$4.17 per share.
Cash & Cash Equivalents | 260.63M |
Total Debt | 521.96M |
Net Cash | -261.33M |
Net Cash Per Share | -$4.17 |
Equity (Book Value) | 668.54M |
Book Value Per Share | 10.68 |
Working Capital | 176.87M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $162.71 million and capital expenditures -$421,000, giving a free cash flow of $162.29 million.
Operating Cash Flow | 162.71M |
Capital Expenditures | -421,000 |
Free Cash Flow | 162.29M |
FCF Per Share | $2.59 |
Full Cash Flow Statement Margins
Gross margin is 84.24%, with operating and profit margins of 51.41% and 18.31%.
Gross Margin | 84.24% |
Operating Margin | 51.41% |
Pretax Margin | 20.95% |
Profit Margin | 18.31% |
EBITDA Margin | 62.71% |
EBIT Margin | 51.41% |
FCF Margin | 47.71% |